Drug development shouldn’t be guesswork, not when patients are waiting.
Pathos is an AI and technology company that develops drugs. Foundry, our platform,
decides which ones.
We are not a biotech that uses AI. We are redesigning drug development from first
principles around an AI and technology core. Our Foundation Model reads across DNA,
RNA, pathology, and clinical text on 200+ petabytes of Multimodal data. Our Foundry
platform turns that model into live portfolio decisions: which asset to invest in, which trial
design to pivot, which program to stop. In 2026, every major portfolio decision
at Pathos was Foundry-informed, a Platform-Informed Decisions score of 4 out of 4.
The three engines of the platform are Scout (finds assets other companies would miss),
Foundry (decides where capital and clinical attention go), and Sprint (executes trials with
AI agents doing the work that used to require a full biotech). We call it a biotech
company in a box.
We are well-capitalized. We have three clinical-stage oncology programs, and a co-development partnership with a top-five pharma. Our leadership has
nearly two decades of company-building experience and multiple successful exits behind
them.
How We Build
Pathos does not operate like a traditional biotech. There is no middle management.
There are no layers of approval. Every function, Clinical, Legal, Finance, Regulatory,
Engineering, Research, is built the same way: small teams of 3-5 subject matter experts,
each commanding 30-50 AI agents to do the work that used to require dozens of people.
Everyone builds. Everyone ships. Product velocity is measured in hours, not weeks. A team of 40-50 operators does the work of a traditional biotech of 300. Every dollar saved
on overhead is a dollar deployed into a clinical program.
The people who thrive here are operators: deep experts who can specify what needs to
happen, orchestrate AI agents to execute at scale, and make high-judgment calls that
compound over time. If you have spent your career building and shipping in your
domain, this is the environment where that experience becomes a superpower.
About the Role
The Director of Clinical Data Management (CDM) will establish and lead the data management function at Pathos. This role reports to the Chief Clinical Operations Officer and is ideal for a hands-on data leader who thrives in high-growth, fast-moving environments and is excited to build CDM strategy, systems, and processes from the ground up.
You will own oversight of clinical data collection, cleaning, and integrity across our oncology trials, ensuring datasets are of the highest quality for analysis, regulatory submissions, and decision-making.
Key Responsibilities
Clinical Data Strategy & Oversight
Execution & Vendor Management
Cross-Functional Collaboration
Leadership & Compliance
What We’re Looking For
This is a hybrid role, requiring 3 days per week onsite, in our NYC Headquarters.
The pay range for this role is:
200,000 - 240,000 USD per year (New York Office - ACLS East Tower)
Clinical
New York, NY
Share on: